TAMARA KLEPPER: Open Payments
NPI 1699724567 · VALLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 11 payments from 8 companies in 2025. Trend: 2023 $192 · 2024 $383 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $141 |
| Amgen Inc. | 2 | $61 |
| United Therapeutics Corporation | 2 | $42 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: SAPIEN 3 Ultra RESILIA, Repatha, Tyvaso, UPTRAVI, NEXLETOL, VERQUVO, WAINUA, Ozempic.
Industry payments across AL — which companies pay providers there.
